iCross × ARCFE Group 6: Another Investor Receives Full $500,000 EB-5 Principal Repayment
- ARCFE-CN
- 4 days ago
- 3 min read
Another eligible investor in iCross × ARCFE Group 6, a pre-RIA EB-5 project, has received a full $500,000 EB-5 principal repayment.
The repayment marks another milestone in Group 6’s ongoing repayment process and adds to iCross × ARCFE’s record of completed investor repayments.
Another Group 6 Investor Receives Full $500,000 EB-5 Principal Repayment
After the applicable repayment conditions under the project documents were met, the investor received the full $500,000 principal repayment.
Privacy Notice: To protect investor privacy, names, bank account information, transaction numbers, and other sensitive information have been redacted.
This latest repayment reflects continued progress for Group 6 and iCross × ARCFE’s focus on long-term project management and investor support.
Speak with our EB-5 specialist and learn how the program can help you achieve permanent residency. Complete the form and our team member will give you a call back.
About ARCFE GROUP 5&6：Bond LIC Condo
ARCFE Group 6 is a pre-RIA EB-5 project sponsored by iCross × ARCFE. Investors participated under the then-applicable minimum investment threshold of $500,000.
The project provided construction financing for two luxury residential developments in Long Island City, Queens—one on 11th Street and the other on 24th Street.
24th Street Project
11th Street Project
Both properties are located in a prime Long Island City growth corridor, directly across the East River from Midtown Manhattan near 57th Street. The neighborhood offers convenient access to Manhattan and has benefited from years of public investment and continued development.
With expanding transportation, retail and residential amenities, Long Island City has become one of New York City’s most active and sought-after residential markets.
Other eligible Group 6 investors had already received principal repayments before this latest transaction. The additional $500,000 repayment continues that progress.
Repayment Milestones Continue Across Pre-RIA and Post-RIA Projects
As of August 2026, all iCross × ARCFE investments that had reached maturity and met the applicable repayment conditions had completed full principal repayment. The remaining investments were still within their contractual terms.
As of that date, no investor principal loss had been recorded across iCross × ARCFE projects, and cumulative principal repayments to eligible investors had reached $116.5 million.
In recent weeks, eligible investors across several iCross × ARCFE projects have received full principal repayments. Previously, the first two post-RIA investors in Group 12 received a combined $1.6 million in principal repayments, while another pre-RIA investor in Group 4 received a full $500,000 principal repayment.
Now, another eligible Group 6 investor has received a full $500,000 principal repayment, further adding to iCross × ARCFE’s repayment track record.
These milestones reflect iCross × ARCFE’s continued focus on disciplined project selection, investment management, project monitoring, and repayment execution.
Backed by iCross Capital’s nearly 20 years of New York City real estate financing experience, iCross × ARCFE applies professional real estate lending standards throughout the EB-5 investment lifecycle—from project evaluation and structuring to ongoing management and repayment.
To learn more about ARCFE’s experience and investment approach, or to evaluate whether EB-5 may fit your family’s immigration plans, request a confidential consultation with the ARCFE team.
Speak with our EB-5 specialist and learn how the program can help you achieve permanent residency. Complete the form and our team member will give you a call back.
Related ARCFE Resources
This update is provided solely to report the status of ARCFE Group 4 as of the publication date. Repayment eligibility and timing are subject to the applicable project documents, investor-specific conditions, and actual project developments. Past performance does not guarantee future results.
